In Depth 19 Jan 2024 Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases? …sporadic Parkinson’s cases are unclear, and molecular mechanisms of Parkinson’s progression are yet to be completely understood. The challenge with studying the underlying mechanisms of Parkinson’s is the complexity of… January 19, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? …the neurodegenerative condition Parkinson’s disease. Galapagos to adjust trial protocol amid parkinsonism concerns for CAR-T candidate GLPG5301 While Galapagos didn’t disclose further details regarding the setback in its half-year finance… August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 25 Oct 2018 Parkinson’s Disease Gene Therapy Clinical Trial Launched in UK A gene therapy for Parkinson’s disease developed by Swiss biotech Axovant has been used on the first patient in a Phase I/II trial at University College London. Parkinson’s disease is… October 25, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 22 Mar 2021 Can Immunotherapy Offer Hope for Parkinson’s Sufferers? Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally provide a solution? More than seven million people worldwide are currently living with Parkinson’s disease,… March 22, 2021 - 5 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2018 Parkinson’s Disease Vaccine Shows Preclinical Promise The biotech company United Neuroscience has developed a candidate Parkinson’s disease vaccine that targets a protein linked to the condition. The vaccine teaches the immune system to attack aggregations of… November 14, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 16 Nov 2018 AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund… November 16, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Apr 2023 6 new vaccines being developed for difficult-to-treat diseases …responses in African populations as were seen in the IAVI G001 trial. ACI-7104: Vaccine for Parkinson’s disease Targeting the protein alpha-synuclein is a common approach when developing treatments for Parkinson’s… April 12, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2022 NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders …($1.2 million) in the project anticipated to take place over a one-year period. Parkinson’s Disease Domainex will be focused on medicines for the treatment of Parkinson’s Disease, motor neuron disease… June 30, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2018 Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease …as Parkinson’s and Alzheimer’s and even traumatic brain injury. The German biotech Hummingbird Diagnostics is developing liquid biopsies that detect miRNA strands involved in Alzheimer’s and Parkinson’s disease. Back in… June 14, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 May 2024 Stem cell therapy’s avant-garde: Eight companies leading the way …into various cell types, hold great potential in regenerative medicine. One of the most notable advancements in stem cell therapy is its application in treating neurodegenerative diseases such as Parkinson’s… May 30, 2024 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 15 Dec 2023 Vaxxinity making vaccines to change the world …disease, Parkinson’s disease, migraine, and hypercholesterolemia. The technology is also being implemented as part of a COVID-19 vaccine program. Vaxxinity has optimized its pipeline to achieve what it said is… December 15, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2022 Muna Therapeutics gets $4.9M grant for Parkinson’s disease research …with Parkinson’s. Kv1.3 plays an important role in creating and maintaining neuroinflammation in Parkinson’s and other neurodegenerative diseases. Reducing neuroinflammation by blocking Kv1.3 has tremendous potential to slow or prevent… October 11, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email